(April 17, 2018)
Today's research and development breakthroughs lie deep in the midst of complex, multivariate data sets. Experimental anomalies and fundamental discoveries often go unnoticed because they are buried in uninterpretable spreadsheets, inaccessible databases, or excessive experimental noise. The cloud-based Riffyn SDE software structures experimental designs and links it to measurement data for machine learning within seconds after it is collected in the lab. We will demonstrate how biotech companies are using this capability to identify unexpected correlations in animal studies, uncover root causes of error in screening experiments, and deliver right-first-time technology scale-up in bioprocess development.
- Research shows that data scientists spend up to 80% of their time performing low value activities (data collation, organization, and cleaning), and only 20% of their time doing the important part — analyzing and learning from that data.
- The goal of the webinar is to illustrate how Riffyn automates data joining, annotation, and collation, shifting the rate limiting step from data organization and cleaning to data analysis, allowing scientists to truly harness the power of machine learning.
Director of Commercial Development
Jarrod is a Director of Commercial Development at Riffyn and is based in Boston. He was previously Product Manager at IDBS and a Consultant prior to that. He has worked extensively with clients in scientific research and development to identify process improvements that can be realized through better data management. Prior to working in Informatics, Jarrod was a bench scientist with experience in bioprocess engineering, microbiology, and molecular biology at EMD Serono, Novartis, and Millennium. He obtained his degree in Biology from Northeastern University and did graduate studies in Biotechnology Engineering at Tufts University.
Laura Jennings-Antipov, Ph.D
Director of Science
Laura Jennings-Antipov is the Director of Science at Riffyn. Prior to joining the Riffyn team, Laura was a team member at Silver Creek Pharmaceuticals, a drug discovery company located in San Francisco. She joined Silver Creek as employee #4 and helped build a research program focused on developing targeted growth factors for regenerative medicine. Laura brings to Riffyn her expertise in assay development and experimental design as well as her experience in simplifying and communicating scientific concepts across disciplines. Laura received a Ph.D. in Biological Chemistry from MIT in 2008 and holds Bachelor's degrees in both Chemistry and Mathematics from the University of Missouri.